Valuation: COMPASS Pathways plc

Market Cap 1.52B 1.34B 1.24B 1.14B 2.15B 146B 2.17B 14.79B 5.78B 72.02B 5.71B 5.59B 249B P/E 2026 *
-12.1x
P/E 2027 * -7.76x
Enterprise Value 1.1B 964M 898M 824M 1.55B 105B 1.57B 10.67B 4.17B 51.94B 4.12B 4.03B 180B EV / Sales 2026 *
-
EV / Sales 2027 * 17.1x
Free-Float
25.07%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: COMPASS Pathways plc

1 day+0.09%
1 week-3.43%
Current month-20.35%
1 month-23.95%
3 months+26.77%
6 months+61.23%
Current year+63.33%
1 week 11.01
Extreme 11.01
12.2
1 month 11.01
Extreme 11.01
15.4
Current year 4.88
Extreme 4.88
15.4
1 year 3.92
Extreme 3.92
15.4
3 years 2.25
Extreme 2.25
15.4
5 years 2.25
Extreme 2.25
49.52
10 years 2.25
Extreme 2.25
61.69
Manager TitleAgeSince
Chief Executive Officer 61 31/07/2022
Director of Finance/CFO 54 29/02/2024
Chief Tech/Sci/R&D Officer 66 30/04/2024
Director TitleAgeSince
Chairman 74 28/03/2024
Director/Board Member 69 31/03/2020
Director/Board Member 67 28/02/2021
Date Insider Type Main position Quantity % Market Cap.
27/05/26 Free

Director

21,110 0.0220%
27/05/26 Free

Director

21,110 0.0220%
27/05/26 Free

Director

21,110 0.0220%
Change 5-day change 1-year change 3-year change Capi.($)
+0.09%-3.43%+160.28%+28.51% 1.52B
+0.07%-0.89%-1.10%+10.78% 47.74B
-0.61%+4.26%+396.16%+647.20% 39.98B
0.00%+4.93%+11.81%+55.56% 36.23B
+2.48%+4.57%+7.05%-5.05% 35.59B
+0.62%+3.53%+5.41%+42.19% 27.91B
-0.17%+0.66% - - 16.71B
-2.00%+11.64%+31.71%+136.81% 16.45B
-0.15%-4.08%+2.14%+7.22% 13.21B
+1.82%+1.56%-9.75%-30.15% 12.93B
Average +0.16%+2.15%+67.08%+99.23% 24.83B
Weighted average by Cap. +0.20%+2.90%+74.64%+135.61%

Financials

2026 *2027 *
Net sales - 59.43M 52.24M 48.63M 44.66M 83.86M 5.7B 84.97M 578M 226M 2.81B 223M 218M 9.73B
Net income -98.16M -86.29M -80.32M -73.77M -139M -9.41B -140M -955M -373M -4.65B -368M -361M -16.07B -198M -174M -162M -149M -279M -18.97B -283M -1.92B -751M -9.36B -742M -726M -32.37B
Net Debt -424M -373M -347M -319M -599M -40.67B -606M -4.13B -1.61B -20.08B -1.59B -1.56B -69.42B -504M -443M -413M -379M -712M -48.36B -721M -4.91B -1.92B -23.88B -1.89B -1.85B -82.54B
Logo COMPASS Pathways plc
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Employees
156
Date Price Change Volume
27/07/26 US$11.27 +0.09% 2,983,857
24/07/26 US$11.26 -3.84% 3,627,158
23/07/26 US$11.71 -1.84% 1,822,118
22/07/26 US$11.93 -2.05% 1,726,461
21/07/26 US$12.18 +4.37% 2,878,936
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
11.27USD
Average target price
23.75USD
Spread / Average Target
+110.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CMPS Stock